193 related articles for article (PubMed ID: 14757851)
41. Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells.
Rossi G; Gasperi V; Paro R; Barsacchi D; Cecconi S; Maccarrone M
Endocrinology; 2007 Mar; 148(3):1431-9. PubMed ID: 17110429
[TBL] [Abstract][Full Text] [Related]
42. Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.
Starowicz K; Makuch W; Osikowicz M; Piscitelli F; Petrosino S; Di Marzo V; Przewlocka B
Neuropharmacology; 2012 Mar; 62(4):1746-55. PubMed ID: 22178705
[TBL] [Abstract][Full Text] [Related]
43. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes.
Maccarrone M; De Petrocellis L; Bari M; Fezza F; Salvati S; Di Marzo V; Finazzi-Agrò A
Arch Biochem Biophys; 2001 Sep; 393(2):321-8. PubMed ID: 11556820
[TBL] [Abstract][Full Text] [Related]
44. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
45. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
[TBL] [Abstract][Full Text] [Related]
46. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.
Sheskin T; Hanus L; Slager J; Vogel Z; Mechoulam R
J Med Chem; 1997 Feb; 40(5):659-67. PubMed ID: 9057852
[TBL] [Abstract][Full Text] [Related]
47. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
48. Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
Karlsson J; Gouveia-Figueira S; Alhouayek M; Fowler CJ
PLoS One; 2017; 12(9):e0185011. PubMed ID: 28910408
[TBL] [Abstract][Full Text] [Related]
49. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
[TBL] [Abstract][Full Text] [Related]
50. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.
Bisogno T; Delton-Vandenbroucke I; Milone A; Lagarde M; Di Marzo V
Arch Biochem Biophys; 1999 Oct; 370(2):300-7. PubMed ID: 10577359
[TBL] [Abstract][Full Text] [Related]
51. Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells.
Maccarrone M; Fiori A; Bari M; Granata F; Gasperi V; De Stefano ME; Finazzi-Agrò A; Strom R
Thromb Haemost; 2006 Jan; 95(1):117-27. PubMed ID: 16543970
[TBL] [Abstract][Full Text] [Related]
52. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.
Price TJ; Patwardhan AM; Flores CM; Hargreaves KM
Neuropharmacology; 2005 Jul; 49(1):25-39. PubMed ID: 15992578
[TBL] [Abstract][Full Text] [Related]
53. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
Hiley CR; Hoi PM
Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
[TBL] [Abstract][Full Text] [Related]
54. Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system.
Amadio D; Fezza F; Catanzaro G; Incani O; van Zadelhoff G; Finazzi Agrò A; Maccarrone M
Biochimie; 2010 Apr; 92(4):378-87. PubMed ID: 20096328
[TBL] [Abstract][Full Text] [Related]
55. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
56. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
57. Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.
Lenman A; Fowler CJ
Br J Pharmacol; 2007 Aug; 151(8):1343-51. PubMed ID: 17592505
[TBL] [Abstract][Full Text] [Related]
58. Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity.
Appendino G; Minassi A; Berton L; Moriello AS; Cascio MG; De Petrocellis L; Di Marzo V
J Med Chem; 2006 Apr; 49(7):2333-8. PubMed ID: 16570929
[TBL] [Abstract][Full Text] [Related]
59. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity.
Patel S; Carrier EJ; Ho WS; Rademacher DJ; Cunningham S; Reddy DS; Falck JR; Cravatt BF; Hillard CJ
J Lipid Res; 2005 Feb; 46(2):342-9. PubMed ID: 15576840
[TBL] [Abstract][Full Text] [Related]
60. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells.
Bari M; Paradisi A; Pasquariello N; Maccarrone M
J Neurosci Res; 2005 Jul; 81(2):275-83. PubMed ID: 15920744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]